(Q36930831)

17 August 2017

Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study (English)

1 reference

17 August 2017

1 reference

Suzanne Carreira

13

0 references

Elena Castro

Elena Castro

9

0 references

Daniel Brewer

Daniel Brewer

2

0 references

Gerhardt Attard

Gerhardt Attard

6

0 references

Shahneen K Sandhu

Shahneen K Sandhu

10

0 references

Charles G. Drake

14

Charles G Drake

1 reference

17 August 2017

17

Howard I Scher

1 reference

17 August 2017

David Olmos

1

1 reference

17 August 2017

Jeremy Clark

3

1 reference

17 August 2017

Daniel C Danila

4

1 reference

17 August 2017

Chris Parker

5

1 reference

17 August 2017

Martin Fleisher

7

1 reference

17 August 2017

Alison Hm Reid

8

1 reference

17 August 2017

Lorraine Barwell

11

1 reference

17 August 2017

Nikhil Babu Oommen

12

1 reference

17 August 2017

Robert Jones

15

1 reference

17 August 2017

Colin S Cooper

16

1 reference

17 August 2017

Johann S de Bono

18

1 reference

17 August 2017

language of work or name

English

0 references

publication date

9 October 2012

1 reference

Lancet Oncology Commission

17 August 2017

1 reference

17 August 2017

13

1 reference

17 August 2017

11

1 reference

17 August 2017

1114-1124

1 reference

Epigenetic biomarkers in prostate cancer: Current and future uses.

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Cell-free nucleic acids as biomarkers in cancer patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Treatment of localized prostate cancer: when is active surveillance appropriate?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Blood and tissue biomarkers in prostate cancer: state of the art.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Gene expression profiling of peripheral blood cells for early detection of breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Hematopoietic Lineage Transcriptome Stability and Representation in PAXgene Collected Peripheral Blood Utilising SPIA Single-Stranded cDNA Probes for Microarray

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Morphological definition of CD71 positive reticulocytes by various staining techniques and electron microscopy compared to reticulocytes detected by an automated hematology analyzer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Assessing the value of risk predictions by using risk stratification tables

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Enabling personalized cancer medicine through analysis of gene-expression patterns

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

MicroRNA signatures in human cancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

The latent process decomposition of cDNA microarray data sets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Single-tube gene-specific expression analysis by high primer density multiplex reverse transcription

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Targeting IGF-1R: throwing out the baby with the bathwater?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

The Determination of Sample Sizes for Use with the Exact Conditional Test in 2 x 2 Comparative Trials

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Altered mode of allelic replication accompanied by aneuploidy in peripheral blood lymphocytes of prostate cancer patients.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Stabilization of mRNA expression in whole blood samples.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878433

Chromosomal instability in cancer patients

4 December 2018

1 reference

12 December 2020

Distribution of Foxp3-, CD4- and CD8-positive lymphocytic cells in benign and malignant prostate tissue

1 reference

12 December 2020

On the Synthesis of RNA in Lymphocytes Stimulated by Phytohemagglutinin. 1. Induction of Uridine-Kinase and the Conversion of Uridine to UTP

1 reference

12 December 2020

Reporting recommendations for tumor marker prognostic studies

1 reference

12 December 2020

The limitations of risk factors as prognostic tools

1 reference

12 December 2020

Aneuploidy index in blood: a potential marker for early onset, androgen response, and metastasis in human prostate cancer

1 reference

12 December 2020

Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970372-8

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S1470-2045(12)70372-8

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

23059046

1 reference